Shares in Andersen, which acquired the rights to the name in 2014, closed 47 per cent higher at $23.50, compared to their IPO price of $16, giving it a fully diluted market capitalisation of about $2.6bn.

A bid by individual investors to grab a sliver of SpaceX before it goes public has propelled a niche ETF into the spotlight, highlighting retail euphoria over Elon Musk’s business empire and the scramble for private-company exposure.

It priced the offering at $29 a share. In its prospectus, the company said it has experienced more than 50 years of consecutive annual sales growth, culminating in sales north of $20 billion every year since 2021. Medline was also the biggest IPO of the year. The company raised $6.26 billion.

Five members of the Illinois-based Mills family joined the three-comma club on Wednesday, as the nearly 60-year-old medical supplies giant that their fathers founded finally went public.

SpaceX has authorized an insider share sale that values Elon Musk's rocket and satellite maker at about $800 billion, according to a company message seen by Bloomberg on Dec. 12.

Elon Musk's SpaceX is eyeing an initial public offering that could be the largest ever, at least partially driven by a plan to launch AI data centers into orbit.

The tepid market debut comes after the Rs 871-crore IPO of Asia's largest dialysis service provider was subscribed 14 times its offer size from December 10-12.

Issue was open for subscription between December 10–12 with a price band of ₹438–460 per share. By the final day of bidding, the Nephrocare Health IPO recieved robust subscription, was booked 13.96 times.